Group One Trading’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Group One Trading's AQST Position: Q3 2026 in Review
Group One Trading opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 5,575 shares worth $25.8K. The stake represents ﹤0.01% of the portfolio and ranks #5988 among its holdings. This is a return to the name: Group One Trading previously reported a position in AQST as recently as Q2 2025.
Group One Trading first reported a position in AQST in Q2 2020 and has held it in 17 quarters since. The position peaked at $297K in Q4 2021. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Group One Trading held 5,575 shares of Aquestive Therapeutics worth $25.8K as of Q3 2026.
- Aquestive Therapeutics was a new Group One Trading position in Q3 2026.
- Aquestive Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5988 holding.
- Group One Trading first reported a position in Aquestive Therapeutics in Q2 2020 and has held it in 17 quarters since.
- Group One Trading's Aquestive Therapeutics position peaked at $297K in Q4 2021.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.